Becky A Robertson Profile picture
Nov 5 8 tweets 4 min read Read on X
What is with these ASD-like symptoms post-covid?

Reports of autistic-like symptoms—such as sensory sensitivities, social withdrawal, executive dysfunction (e.g., brain fog, difficulty planning or communicating), repetitive behaviors, & emotional dysregulation—appearing or intensifying after COVID-19 infections have indeed risen, particularly in the context of long COVID (symptoms persisting beyond 12 weeks post-infection). This isn’t necessarily “causing” autism spectrum disorder (ASD), which is a neurodevelopmental condition rooted in genetics & early brain wiring, but rather leading to “acquired neurodivergence” where neurological changes mimic or exacerbate ASD traits in both neurotypical individuals & those already on the spectrum.

Emerging research suggests this trend may contribute to observed increases in ASD prevalence rates (e.g., from 1 in 36 children in 2020 to 1 in 31 by mid-2024), though diagnostic shifts, heightened awareness, & pandemic stressors also play roles.

Why This Is Happening: Key Mechanisms

Long COVID triggers persistent systemic inflammation and immune dysregulation that can disrupt brain function, echoing pathways implicated in ASD. A theoretical framework outlines how SARS-CoV-2 infection interacts with genetic vulnerabilities during critical developmental windows (e.g., prenatal or early postnatal periods), potentially amplifying neurodevelopmental traits.

Here’s a breakdown of the primary mechanisms:

1/ASD-like symptoms/behaviors
1Neuroinflammation & Microglial Overactivation:

COVID-19 leaves behind viral proteins that sustain elevated pro-inflammatory cytokines (e.g., IL-6 and TNF-α levels 2–3 times higher than baseline, persisting for months). This activates microglia (brain immune cells), impairing synaptic pruning—the process that refines neural connections in early development—and leading to altered brain circuits. In ASD, similar inflammation disrupts social processing and sensory integration; in long COVID, it manifests as heightened sensory overload or repetitive stimming-like behaviors to self-regulate.

2/ASD-like symptoms/behaviors
2Blood-Brain Barrier (BBB) Dysfunction:

The virus compromises the BBB (seen in 40–60% of cases within days of infection), allowing inflammatory molecules to infiltrate the brain. This can cause microvascular damage, reduced gray matter volume (up to 2% brain shrinkage even in mild cases), and cognitive declines resembling ASD’s executive challenges, like trouble with word recall or emotional meltdowns from overload.

3Autoimmune & Epigenetic Effects:

Long COVID induces autoantibodies targeting brain cells (in 15–25% of patients), similar to maternal autoantibodies linked to ASD risk. Epigenetic changes from chronic immune stress may “switch on” ASD-related genes without altering DNA, unmasking latent traits. Anecdotal reports describe sudden shifts, like a previously outgoing person struggling with “how to be human” in social settings or experiencing PTSD-like meltdowns from sensory input post-infection.

3/ASD-like symptoms/behaviors
4Gut-Brain Axis & Hormonal Disruptions:

Viral persistence may alter the microbiome or lower cortisol, inflaming the nervous system & worsening anxiety or fatigue—overlaps with ASD co-occurring conditions like chronic fatigue syndrome.

These effects are bidirectional: Higher autistic traits increase long COVID risk (e.g., via sensory masking during infection), creating a feedback loop where symptoms compound. Brain imaging shows overlaps in affected regions (e.g., olfactory & salience networks), and user experiences highlight rapid onset, like brain fog triggering realizations of undiagnosed neurodivergence.

4/ASD-like symptoms/behaviors
What Can Be Done: Management & Treatment Strategies

While there’s no “cure” for long COVID or ASD traits, a multi-pronged approach focuses on reducing inflammation, supporting brain recovery, & adapting environments. Always consult a healthcare provider (e.g., neurologist or psychiatrist) for personalized plans, as symptoms vary.

Here’s what’s showing promise:

1. Lifestyle & Behavioral Interventions
•Pacing & Energy Management: Break tasks into short bursts to combat fatigue & overload; tools like timers help with executive function.
•Sensory & Environmental Supports: Reduce stimuli (e.g., noise-canceling headphones, dim lighting) and use accommodations like flexible work hours or hybrid setups. Disability coaching or occupational therapy (OT) can teach coping strategies, improving self-perception & reducing anxiety.

5/ASD-like symptoms/behaviors
What Can Be Done: Management & Treatment Strategies, cont …

•Cognitive Behavioral Therapy (CBT) or Mindfulness: Adapted for neurodivergence, this addresses emotional dysregulation & social challenges; apps like Calm aid sensory regulation.
•Diet & Exercise: Anti-inflammatory diets (e.g., Mediterranean-style, rich in omega-3s) and gentle movement (yoga, walking) support gut-brain health and cortisol balance.

2. Medications & Emerging Therapies
•For Brain Fog & Executive Dysfunction: N-acetylcysteine (NAC, an antioxidant) and guanfacine (an ADHD med that stabilizes neural signaling) have relieved symptoms in small studies, with patients reporting clearer thinking within weeks. Start low-dose under supervision.

6/ASD-like symptoms/behaviors
What Can Be Done: Management & Treatment Strategies, cont …

•Anti-Inflammatories: JAK inhibitors like upadacitinib (15–30 mg daily) showed rapid improvements in neuropsychiatric symptoms (e.g., reduced aggression, better cognition) in case reports of ASD patients with long COVID exacerbations, often combined with colchicine for immune modulation. These target cytokine storms but require monitoring for side effects.
•Other Options: Low-dose steroids or IVIg for autoimmune flares; antidepressants (e.g., SSRIs) if anxiety dominates. Vaccines may prevent severe reinfections that worsen symptoms.

7/ASD-like symptoms/behaviors
3. Long-Term Support
•Screening & Early Intervention: For at-risk groups (e.g., children of COVID-exposed pregnancies), monitor inflammation via blood tests and use AI tools for symptom prediction.
•Advocacy & Community: Recognize long COVID as a potential disability for legal protections (e.g., ADA accommodations). Peer support groups (e.g., on Reddit) validate experiences and share tips.
Research is evolving, with trials underway for targeted therapies. If symptoms persist, seek multidisciplinary care—early action can significantly improve quality of life.

8/ASD-like symptoms/behaviors

~fin~ Not medical advice. Ask your Dr.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Becky A Robertson

Becky A Robertson Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @AnciraBecky

Oct 16
What is with all the talk about Valacyclovir & Celecoxib lately?

The Valtrex (valacyclovir) and Celecoxib trial for Long COVID, often referred to in the context of the IMC-2 regimen (a combination of valacyclovir and celecoxib), is a collaborative effort involving researchers David Putrino from the Icahn School of Medicine at Mount Sinai and William Pridgen from Tuscaloosa Surgical Associates/PridCor Therapeutics. PolyBio Research Foundation provided support for manuscript preparation in the key publication detailing the study, as part of their broader funding and collaboration on Long COVID research, including antiviral trials through their Long COVID Research Consortium, which includes Putrino’s institution. 52 This aligns with PolyBio’s focus on infection-associated chronic illnesses, viral persistence, and catalyzing clinical trials for Long COVID treatments. 40 45
Study Background and Design
The research stems from the hypothesis that Long COVID symptoms may be driven by persistent SARS-CoV-2 infection and/or reactivation of herpesviruses (like EBV or HSV), which antivirals could target. 52 31 IMC-2 was originally explored by Pridgen for conditions like fibromyalgia, where celecoxib (an anti-inflammatory NSAID) is thought to enhance valacyclovir’s antiviral effects by improving tissue penetration and modulating immune responses. 52 17
This specific study, conducted from April 2022 to February 2024 at an outpatient clinic in Alabama, was an open-label case series (a preliminary observational study, not a full randomized controlled trial) involving 24 adults with Long COVID (symptomatic for at least 5 months, meeting CDC and NASEM criteria). 52 Participants were divided into two groups:
•IMC-2 Only (IO): 12 patients took valacyclovir (1,000 mg three times daily) plus celecoxib (200 mg twice daily) for 120 days.
•IMC-2 + Paxlovid (IP): 12 patients took the (IP): 12 patients took the same IMC-2 regimen but added a 15-day pulsed course of Paxlovid (nirmatrelvir/ritonavir, an anti-SARS-CoV-2 drug) starting around day 30-45, with some dose adjustments. Three IO patients later crossed over to IP.
Read 24 tweets
Sep 19
Lyme disease and Long COVID share several overlapping characteristics, particularly in their chronic or persistent forms, as both can lead to prolonged, multisystem symptoms that significantly impact quality of life. Below, I outline the key commonalities based on available medical understanding:
1. Chronic Fatigue: Both conditions often present with profound, debilitating fatigue that doesn’t improve with rest. In Lyme disease, this is a hallmark of post-treatment Lyme disease syndrome (PTLDS), while in Long COVID, it’s commonly referred to as post-exertional malaise or chronic fatigue.
2. Cognitive Dysfunction: Patients with both conditions frequently report “brain fog,” including difficulties with memory, concentration, and mental clarity. In Lyme disease, this is sometimes called Lyme encephalopathy, while in Long COVID, it’s a widely recognized neurological symptom.
3. Musculoskeletal Pain: Persistent joint and muscle pain are common in both. Lyme disease, caused by the Borrelia bacteria, often leads to migratory joint pain or arthritis, while Long COVID patients report myalgia and arthralgia, often without clear inflammation.
4. Neurological Symptoms: Both can involve neurological issues such as headaches, dizziness, and nerve pain (neuropathy). Lyme disease may cause Bell’s palsy or radiculopathy, while Long COVID can lead to similar neuropathic symptoms or autonomic dysfunction like postural orthostatic tachycardia syndrome (POTS).
5. Autonomic Dysfunction: Both conditions can disrupt the autonomic nervous system, leading to symptoms like heart rate irregularities, blood pressure fluctuations, or intolerance to standing (orthostatic intolerance). POTS is increasingly noted in both Long COVID and chronic Lyme patients.
6. Multisystem Involvement: Both affect multiple organ systems, including the nervous, cardiovascular, and immune systems. Lyme disease can lead to carditis or meningitis in severe cases, while Long COVID may involve cardiovascular complications or persistent respiratory issues.
7. Immune Dysregulation: Both conditions are associated with immune system abnormalities. Lyme disease may trigger autoimmunity or persistent immune activation, while Long COVID is hypothesized to involve immune dysregulation, possibly due to lingering viral components or autoantibodies.
Read 7 tweets
Sep 19
Overview of the ACIP Meeting on September 18-19, 2025
The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) held its virtual meeting on September 18-19, 2025, focusing on updates to vaccine recommendations, particularly those affecting pediatric and adult immunization schedules. The committee, recently reconstituted under Health and Human Services Secretary Robert F. Kennedy Jr., reviewed evidence on measles, mumps, rubella, and varicella (MMRV) vaccines, hepatitis B (Hep B) vaccines, and 2024-2025 COVID-19 vaccine implementation. Votes occurred primarily on Day 1 (September 18), with some deferred to Day 2. Discussions highlighted tensions between evidence-based safety data from CDC experts and skepticism from some ACIP members, leading to notable disarray, including confusion over vote wording and rationales.
The outcomes primarily impact pediatric vaccine schedules, emphasizing shared clinical decision-making (individualized risk-benefit discussions) over universal recommendations. No major changes were finalized for adult schedules on Day 1, though COVID-19 discussions continued. These recommendations, if adopted by the CDC Director, influence insurance coverage (e.g., no-cost sharing under the Affordable Care Act), Vaccines for Children (VFC) program eligibility, and pharmacy administration authority. However, America’s Health Insurance Plans (AHIP) stated that all ACIP-recommended immunizations as of September 1, 2025, will remain covered without changes, potentially buffering immediate access disruptions. Some states have also signaled they may not follow revised ACIP guidance.
Key Outcomes on Vaccine Schedules
1. MMRV Vaccine (Measles, Mumps, Rubella, and Varicella)
• Background: The combined MMRV vaccine (e.g., ProQuad) is currently recommended as an option for the first dose at 12-47 months to reduce injections, but ACIP has long advised separate MMR and varicella vaccines for the first dose due to a slightly elevated risk of febrile seizures (temporary, non-life-threatening events peaking at 14-18 months). Evidence presented showed the risk is about 1 extra seizure per 2,300-3,000 doses, with no long-term harm.
• Vote Outcome (September 18): ACIP voted to withdraw the recommendation for MMRV as the first dose in children under 2 years, mandating separate MMR and varicella vaccines instead. This passed by majority vote (exact tally not specified in real-time reports, but described as clear).
Read 9 tweets
Aug 29
App-𝙤𝙧𝙩𝙪𝙣𝙞𝙩𝙮 𝙛𝙤𝙧 𝙞𝙢𝙥𝙧𝙤𝙫𝙚𝙢𝙚𝙣𝙩?

Everyone keeps talking about developing an app for #LongCovid & I would hate for anyone to recreate the wheel. Are you looking to track symptoms, recovery, treatment, exercise, vitals, pacing, sleep (or lack of), diet and/or sleep? Maybe a few of these designers could collaborate. 🤷‍♀️

I currently track my data/stats with 𝙐𝙣𝙝𝙞𝙙𝙚, 𝙈𝙮𝘿𝙖𝙩𝙖𝙃𝙚𝙡𝙥𝙨, 𝙎𝙘𝙧𝙞𝙥𝙥𝙨, CDC Surveys (and bloodwork) & don 2 wearable devices. I love contributing to Science. 😃

I've compiled a list of the top 20 apps used by #LongCovid patients in hopes we might encourage collaboration or select all of the best features and/or formats to create THE all-encompassing interactive app/database for our community, our caregivers & doctors in realtime.

Which apps do you find helpful?
1/
•               Visible: A pacing and symptom-tracking app tailored for Long COVID and ME/CFS (chronic fatigue syndrome). It uses smartphone camera-based heart rate variability (HRV) measurements, symptom logging, and activity data to help users avoid overexertion (post-exertional malaise). Features include daily “pace scores,” trend analysis, breathing exercises, and optional integration with wearables for all-day monitoring. It emphasizes rest over fitness, with reports for sharing with doctors. Available on iOS and Android; free basic version, premium subscription for advanced features.
2/
•               Long COVID Companion: A voice-based app from the Luxembourg Institute of Health for people with Long COVID. It acts as a daily companion to track symptoms, treatments, progress, quality of life, & health metrics over time. Users can log data verbally for ease, with features for pattern recognition and sharing with clinicians. Free on iOS & Android.
3/Image
Image
Image
Read 17 tweets
Aug 25
𝙄'𝙫𝙚 𝙘𝙤𝙡𝙡𝙚𝙘𝙩𝙚𝙙 𝙩𝙝𝙤𝙪𝙨𝙖𝙣𝙙𝙨 𝙤𝙛 𝙥𝙖𝙥𝙚𝙧𝙨/𝙨𝙩𝙪𝙙𝙞𝙚𝙨 𝙤𝙫𝙚𝙧 𝙩𝙝𝙚 𝙥𝙖𝙨𝙩 6 𝙮𝙚𝙖𝙧𝙨 𝙖𝙣𝙙 𝙩𝙝𝙚𝙮 𝘼𝙇𝙇 𝙝𝙖𝙫𝙚 𝙩𝙝𝙚 𝙨𝙖𝙢𝙚 𝙘𝙤𝙣𝙘𝙡𝙪𝙨𝙞𝙤𝙣-

𝘾𝙊𝙑𝙄𝘿 𝘾𝘼𝙐𝙎𝙀𝙎 𝘽𝙍𝘼𝙄𝙉 𝘿𝘼𝙈𝘼𝙂𝙀!!
🦠 🧠 🦠
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19

link.springer.com/article/10.100…
Neurological Involvement in COVID-19 and Potential Mechanisms: A Review
Review Article
Published: 13 July 2020

link.springer.com/article/10.100…
COVID-19-Induced Neurovascular Injury: a Case Series with Emphasis on Pathophysiological Mechanisms
Covid-19
Published: 22 October 2020

link.springer.com/article/10.100…
Read 8 tweets
Aug 4
**COVID-19 can induce lupus**
🔬🩺🧬🩸🧪🩹💉🩻🦠💊🌡
(systemic lupus erythematosus, SLE) through several immune system mechanisms, especially in genetically predisposed individuals:
**Immune System Hyperactivation:**
COVID-19 triggers a strong immune response. The virus can cause excessive activation of B-cells (antibody-producing cells) and promote overproduction of interferons, both of which are implicated in lupus pathogenesis. This abnormal activation may lead to the immune system mistakenly attacking healthy body tissues—a hallmark of lupus.
1/
**Production of Autoantibodies:**
COVID-19 has been found to stimulate the immune system in a way that leads to the formation of autoantibodies (antibodies that target the body’s own proteins. Autoantibodies such as antinuclear antibodies & lupus anticoagulant are commonly associated with lupus & have been detected in some COVID-19 patients.
2/
**Triggering Disease in Susceptible Hosts:**
Environmental factors like viral infections—including SARS-CoV-2—have long been recognized as possible triggers for new-onset lupus & lupus flare-ups, particularly in people with a genetic predisposition. Wooohoo 😣
3/
Read 21 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(